InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Feder Julie B, Chief Financial Officer. Director active across 1 companies, notably Aura Biosciences, Inc.. Cumulatively, 2 filings have been logged. The latest transaction was filed on 28 October 2021 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
026,250 shares0
Common Stock
SEC:0000899243-21-042083·
026,250 shares0
Common Stock
SEC:0000899243-21-042083:0·
2 of 2 declarations
About Feder Julie B
Julie B. Feder is the Chief Financial Officer of Aura Biosciences, Inc. She oversees the company's financial operations, including financial planning and risk management. With a strong background in finance, she plays a key role in Aura Biosciences' financial strategy.
